Your browser doesn't support javascript.
loading
Digital mammography screening in Germany: Impact of age and histological subtype on program sensitivity.
Heidinger, Oliver; Heidrich, Jan; Batzler, Wolf Ulrich; Krieg, Volker; Weigel, Stefanie; Heindel, Walter; Hense, Hans-Werner.
Afiliação
  • Heidinger O; Epidemiological Cancer Registry North Rhine-Westphalia, Münster, Germany. Electronic address: Oliver.Heidinger@krebsregister.nrw.de.
  • Heidrich J; Epidemiological Cancer Registry North Rhine-Westphalia, Münster, Germany.
  • Batzler WU; Epidemiological Cancer Registry North Rhine-Westphalia, Münster, Germany.
  • Krieg V; Epidemiological Cancer Registry North Rhine-Westphalia, Münster, Germany.
  • Weigel S; Department of Clinical Radiology and Reference Center for Mammography, Faculty of Medicine, University Hospital Münster, Germany.
  • Heindel W; Department of Clinical Radiology and Reference Center for Mammography, Faculty of Medicine, University Hospital Münster, Germany.
  • Hense HW; Epidemiological Cancer Registry North Rhine-Westphalia, Münster, Germany; Institute of Epidemiology and Social Medicine, Faculty of Medicine, University of Münster, Germany.
Breast ; 24(3): 191-6, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25687106
ABSTRACT

INTRODUCTION:

Program sensitivity (PS), i.e., the ratio of screen-detected cancers divided by the sum of screen-detected plus interval cancers, is a major outcome in population-based mammography screening programs (MSP). This study evaluated PS within the digital MSP in Germany focussing on the impact of age and histological subtype.

METHODS:

Data of 838,579 first-time participants aged 50-69 years who were screened in 2005-2008 were linked with cancer registry data from Germany's most populous state, North Rhine-Westphalia. Invasive breast cancers and ductal carcinomas in situ (DCIS) were detected either at screening or during the 24 month post-screening interval. PS was evaluated with respect to age at screening, in-situ or invasive cancer and histological characteristics.

RESULTS:

In total, 6767 cancers were detected at screening and 1884 cancers were diagnosed during the post-screening interval. The overall PS amounted to 78.2% and increased from 72.1% at age 50-54 years to 82.4% at age 65-69 years (p for trend <0.0001). PS was higher for non-lobular (79.1%) than lobular carcinomas (72.1%, p < 0.0001). The highest PS was observed in DCIS across all ages (>90%), while PS was lowest among participants aged 50-54 years with invasive breast cancer (67.7%), particularly among those with lobular subtype (62.8%). Interval cancers showed generally more advanced tumour stages.

CONCLUSIONS:

While overall PS was high, differences across subgroups indicated that youngest screening participants are at higher risk of interval cancer. Age-adapted recall and assessment strategies in younger participants may need to be considered to improve PS in younger women.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mamografia / Avaliação de Programas e Projetos de Saúde / Carcinoma Lobular / Carcinoma Ductal de Mama / Detecção Precoce de Câncer Tipo de estudo: Diagnostic_studies / Evaluation_studies / Screening_studies Limite: Aged / Female / Humans / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mamografia / Avaliação de Programas e Projetos de Saúde / Carcinoma Lobular / Carcinoma Ductal de Mama / Detecção Precoce de Câncer Tipo de estudo: Diagnostic_studies / Evaluation_studies / Screening_studies Limite: Aged / Female / Humans / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article